Commodore Capital LP - 31 Dec 2025 SCHEDULE 13G/A Report for Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share (VTGN)

Filing Manager
Commodore Capital LP
Reporting Manager
Commodore Capital LP
Security
Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
VTGN
Shares outstanding
44,277,859 shares
Disclosed Ownership
4,383,508 shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:26:03 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Commodore Capital LP 9.9% 4,383,508 0 4,383,508 Michael Kramarz Managing Partner
Commodore Capital Master LP 9.9% 4,383,508 0 4,383,508 Michael Kramarz Authorized Signatory
Robert Egen Atkinson 9.9% 4,383,508 0 4,383,508 Robert Egen Atkinson Authorized Signatory
Michael Kramarz 9.9% 4,383,508 0 4,383,508 Michael Kramarz Authorized Signatory